Last update 23 Jan 2025

PDE1 x PDE4 x MMP12

Basic Info

Related Targets
PDE1PDE4MMP12

Related

1
Drugs associated with PDE1 x PDE4 x MMP12
GPD-1116
Target
MMP12 x PDE1 x PDE4
Mechanism
MMP12 inhibitors [+2]
Active Org.-
Originator Org.
ASKA Pharmaceutical Co., Ltd.ASKA Pharmaceutical Co., Ltd.
Active Indication-
Inactive Indication
Allergic asthma [+2]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with PDE1 x PDE4 x MMP12
EUCTR2008-005813-23-GB
/ Not yet recruitingNot Applicable
Phase IIa study to evaluate the effects of GPD-1116 on late phase asthmatic response to allergen challenge in asthmatic patients.
100 Clinical Results associated with PDE1 x PDE4 x MMP12
Login to view more data
100 Translational Medicine associated with PDE1 x PDE4 x MMP12
Login to view more data
0 Patents (Medical) associated with PDE1 x PDE4 x MMP12
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free